Depletion of Coagulation Factor XII Ameliorates Brain Pathology and Cognitive Impairment in Alzheimer Disease Mice

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2017 Mar 1

PMID 28242605

Citations 53

Authors

Zu-Lin Chen

Alexey S Revenko

Pradeep Singh

A Robert MacLeod

Erin H Norris

Sidney Strickland

Affiliations

Soon will be listed here.

Abstract

Vascular abnormalities and inflammation are found in many Alzheimer disease (AD) patients, but whether these changes play a causative role in AD is not clear. The factor XII (FXII) -initiated contact system can trigger both vascular pathology and inflammation and is activated in AD patients and AD mice. We have investigated the role of the contact system in AD pathogenesis. Cleavage of high-molecular-weight kininogen (HK), a marker for activation of the inflammatory arm of the contact system, is increased in a mouse model of AD, and this cleavage is temporally correlated with the onset of brain inflammation. Depletion of FXII in AD mice inhibited HK cleavage in plasma and reduced neuroinflammation, fibrinogen deposition, and neurodegeneration in the brain. Moreover, FXII-depleted AD mice showed better cognitive function than untreated AD mice. These results indicate that FXII-mediated contact system activation contributes to AD pathogenesis, and therefore this system may offer novel targets for AD treatment.

Citing Articles

A Bibliometric Analysis of Macrophage Research Associated with Periodontitis Over the Past Two Decades.

Qiu Y, Ding Z, Yang D Int Dent J. 2024; 75(1):363-374.

PMID: 39672778 PMC: 11806299. DOI: 10.1016/j.identj.2024.11.016.

Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies.

Yue Q, Leng X, Xie N, Zhang Z, Yang D, Man Hoi M CNS Neurosci Ther. 2024; 30(11):e70079.

PMID: 39548663 PMC: 11567945. DOI: 10.1111/cns.70079.

Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors.

Dumas A, Goyal N, Mottamal M, Afosah D, Al-Horani R J Thromb Thrombolysis. 2024; 57(8):1308-1314.

PMID: 39487279 DOI: 10.1007/s11239-024-03054-2.

A multi-ethnic proteomic profiling analysis in Alzheimer's disease identifies the disparities in dysregulation of proteins and pathogenesis.

Tan M, Cheah P, Chin A, Looi L, Chang S PeerJ. 2024; 12:e17643.

PMID: 39035156 PMC: 11260413. DOI: 10.7717/peerj.17643.

Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration.

Le N, Han C, Delila L, Nebie O, Chien H, Wu Y APL Bioeng. 2024; 8(2):026111.

PMID: 38726021 PMC: 11080963. DOI: 10.1063/5.0196553.

References

Vermeer S, Prins N, den Heijer T, Hofman A, Koudstaal P, Breteler M . Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348(13):1215-22. DOI: 10.1056/NEJMoa022066. View

Bowman G, Kaye J, Moore M, Waichunas D, Carlson N, Quinn J . Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology. 2007; 68(21):1809-14. PMC: 2668699. DOI: 10.1212/01.wnl.0000262031.18018.1a. View

Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

Paul J, Strickland S, Melchor J . Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med. 2007; 204(8):1999-2008. PMC: 2118680. DOI: 10.1084/jem.20070304. View

Chi N, Chien L, Ku H, Hu C, Chiou H . Alzheimer disease and risk of stroke: a population-based cohort study. Neurology. 2013; 80(8):705-11. DOI: 10.1212/WNL.0b013e31828250af. View

Renne T, Pozgajova M, Gruner S, Schuh K, Pauer H, Burfeind P . Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med. 2005; 202(2):271-81. PMC: 2213000. DOI: 10.1084/jem.20050664. View

Norris E, Strickland S . Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci U S A. 2007; 104(33):13473-8. PMC: 1948906. DOI: 10.1073/pnas.0705848104. View

van Rooden S, Goos J, van Opstal A, Versluis M, Webb A, Blauw G . Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging. Radiology. 2013; 270(1):205-11. DOI: 10.1148/radiol.13130743. View

Shibayama Y, Joseph K, Nakazawa Y, Ghebreihiwet B, Peerschke E, Kaplan A . Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Clin Immunol. 1999; 90(1):89-99. DOI: 10.1006/clim.1998.4621. View

10.

Selkoe D, Hardy J . The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8(6):595-608. PMC: 4888851. DOI: 10.15252/emmm.201606210. View

11.

Ryu J, McLarnon J . A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med. 2008; 13(9A):2911-25. PMC: 4498946. DOI: 10.1111/j.1582-4934.2008.00434.x. View

12.

Maas C, Govers-Riemslag J, Bouma B, Schiks B, Hazenberg B, Lokhorst H . Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest. 2008; 118(9):3208-18. PMC: 2518075. DOI: 10.1172/JCI35424. View

13.

Ahn H, Glickman J, Poon K, Zamolodchikov D, Jno-Charles O, Norris E . A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J Exp Med. 2014; 211(6):1049-62. PMC: 4042638. DOI: 10.1084/jem.20131751. View

14.

Hayes A, Thaker U, Iwatsubo T, Pickering-Brown S, Mann D . Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease. Neurosci Lett. 2002; 331(3):171-4. DOI: 10.1016/s0304-3940(02)00888-1. View

15.

Prediger R, Medeiros R, Pandolfo P, Duarte F, Passos G, Pesquero J . Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience. 2008; 151(3):631-43. DOI: 10.1016/j.neuroscience.2007.11.009. View

16.

Chen Z, Yu H, Yu W, Pawlak R, Strickland S . Proteolytic fragments of laminin promote excitotoxic neurodegeneration by up-regulation of the KA1 subunit of the kainate receptor. J Cell Biol. 2008; 183(7):1299-1313. PMC: 2606967. DOI: 10.1083/jcb.200803107. View

17.

Davalos D, Ryu J, Merlini M, Baeten K, Le Moan N, Petersen M . Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012; 3:1227. PMC: 3514498. DOI: 10.1038/ncomms2230. View

18.

Fiala M, Liu Q, Sayre J, Pop V, Brahmandam V, Graves M . Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest. 2002; 32(5):360-71. DOI: 10.1046/j.1365-2362.2002.00994.x. View

19.

Musiek E, Holtzman D . Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat Neurosci. 2015; 18(6):800-6. PMC: 4445458. DOI: 10.1038/nn.4018. View

20.

Bayer T, Buslei R, Havas L, Falkai P . Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett. 1999; 271(2):126-8. DOI: 10.1016/s0304-3940(99)00545-5. View